---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-052952"
form_type: "8-K"
ticker: "NUTX"
cik: "0001479681"
company_name: "Nutex Health Inc."
filed_at: "2025-11-18T23:59:59+00:00"
generated_at: "2026-05-16T18:45:36.474492+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Nutex Health restates Q1 2025: revenue $211.8M, net income $21.2M, diluted EPS $3.33

## Summary
- Total revenue $211.8M, up 214% YoY from $67.5M.
- Net income attributable to Nutex $21.2M vs net loss $0.4M in Q1 2024.
- Diluted EPS $3.33 vs loss per share $0.08.
- Adjusted EBITDA $72.8M vs $(0.4)M prior year.
- Net cash from operating activities of $51.0M for Q1 2025.

## SEC filing metadata
- accession: 0001628280-25-052952
- form_type: 8-K
- ticker: NUTX
- cik: 0001479681
- company_name: Nutex Health Inc.
- filed_at: 2025-11-18T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479681/000162828025052952/0001628280-25-052952-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479681/000162828025052952/nutx-20251118.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-052952
- JSON: https://secwatch.observer/filing/0001628280-25-052952.json
- Plain text: https://secwatch.observer/filing/0001628280-25-052952.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.